EP3777834
Sprauta
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.5.2013EP published:
16.2.2022EP application number:
20198921.7
EP translation filed:
3.5.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
29.5.2033Expiry date:
29.5.2023
Title in English:
SYRINGELanguage of the patent:
English
Timeline
Today
30.5.2013EP application
16.2.2022EP Publication
3.5.2022Translation submitted
15.6.2022Registration published
29.5.2023Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BRYANT, AndrewAddress:
4002 Basel, CH
Name:
BUETTGEN, HeinrichAddress:
4002 Basel, CH
Name:
PAPST, WolfgangAddress:
4002 Basel, CH
Name:
PICCI, MarieAddress:
4002 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
12170628Date:
1.6.2012Country:
EP
Classification
Categories:
A61K 9/00, A61M 5/28, A61M 5/31, A61M 5/315, A61P 43/00, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 2.5.2022
Expires: 29.5.2023
Payer: Árnason Faktor ehf.